Issue 3/2008
Personalized cancer medicine
Content (13 Articles)
Proteomics, a new tool to monitor cancer therapy?
J. Loeffler-Ragg, B. Sarg, D. Mueller, T. Auer, H. Lindner, H. Zwierzina
Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation
K. Prassl, A. Sahanic, B. Reicher, H. Denz, M. Freund, M. Fiegl
Ocular abnormality as the first sign of metastatic breast cancer: the presentation of two cases
Z. Kahán, Á. Szabó, A. Cserháti
"Old tricks and new procedures" – a report from the 34th Annual Meeting of the European Group for Blood and Marrow Transplantation EBMT, March 30 – April 2, 2008, Florence, Italy
E. Willenbacher, W. Willenbacher
Treatment options in localised and metastatic renal cell carcinoma
A. P. Berger, A. Hobisch
Individualized molecular cancer therapy based on radiolabelled somatostatin analogues
M. Gabriel, U. Andergassen, I. J. Virgolini
Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients
G. Fritsche, G. Weiss